We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Editorial: Chemo-Radiation-Resistance in Cancer Therapy.
- Authors
Lin, Xiaoping; Kong, Dexin; Chen, Zhe-Sheng
- Abstract
In DOX-resistant breast cancer cells, P- glycoprotein protein can pump DOX out of MCF-7/DOX cells, as a result, DOX fails to exert effective cytotoxic effect and breast cancer cells can evade attack of chemotherapeutics. Nevertheless, successful cancer therapy remains a major challenge, particularly in tumors that are resistant to chemotherapy or radiation therapy. Keywords: chemothearpy resistance; radiationtherapy resistance; cancer; chemoradiation resistance; therapy EN chemothearpy resistance radiationtherapy resistance cancer chemoradiation resistance therapy 1 6 6 05/23/22 20220518 NES 220518 In recent years, technical advances in chemotherapy and radiotherapy have helped substantially improve the treatment outcome and quality of life of cancer patients. Immune-related lncRNAs, which were identified as a prognostic marker of various types of cancer, are markedly connected with immune cell infiltration, and might be a potential target for cancer treatment.
- Subjects
METHYLGUANINE; PACLITAXEL; CANCER treatment; NOGO protein; PROGNOSIS; TUMOR suppressor proteins; MEDICAL care; PURINERGIC receptors
- Publication
Frontiers in Pharmacology, 2022, Vol 13, p1
- ISSN
1663-9812
- Publication type
Article
- DOI
10.3389/fphar.2022.904063